Myriam Curet is Director of Stereotaxis, Inc.. Currently has a direct ownership of 244,945 shares of STXS, which is worth approximately $480,092. The most recent transaction as insider was on Jul 01, 2024, when has been sold 53,475 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 245K
0% 3M change
93.58% 12M change
Total Value Held $480,092

Myriam Curet Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
BUY
Grant, award, or other acquisition
-
53,475 Added 17.92%
244,945 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
64,935 Added 25.33%
191,470 Common Stock
Jul 03 2023
BUY
Grant, award, or other acquisition
-
47,619 Added 27.34%
126,535 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
54,054 Added 40.65%
78,916 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
-
15,527 Added 38.44%
24,862 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
-
9,335 Added 50.0%
9,335 Common Stock

Also insider at

ISRG
INTUITIVE SURGICAL INC Healthcare
NKTR
NEKTAR THERAPEUTICS Healthcare
INSP
Inspire Medical Systems, Inc. Healthcare
MC

Myriam Curet

Director
Sunnyvale, CA

Track Institutional and Insider Activities on STXS

Follow Stereotaxis, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STXS shares.

Notify only if

Insider Trading

Get notified when an Stereotaxis, Inc. insider buys or sells STXS shares.

Notify only if

News

Receive news related to Stereotaxis, Inc.

Track Activities on STXS